Abacavir, dolutegravir, and lamivudine
Generic name: abacavir, dolutegravir, and lamivudine [ a-BAK-a-vir, DOE-loo-TEG-ra-vir, la-MIV-ue-deen ]
Brand names: Triumeq, Triumeq PD
Dosage forms: oral tablet (600 mg-50 mg-300 mg); oral tablet, dispersible (60 mg-5 mg-30 mg)
Drug class:Antiviral combinations
What is abacavir, dolutegravir, and lamivudine?
Abacavir, dolutegravir, and lamivudine is a combination medicine used to treat human immunodeficiency virus (HIV), the virus that can cause acquired immunodeficiency syndrome (AIDS). abacavir, dolutegravir, and lamivudine is not a cure for HIV or AIDS.
Abacavir, dolutegravir, and lamivudine is for use in adults and children who weigh at least 22 pounds (10 kilograms).
Abacavir, dolutegravir, and lamivudine should not be used by itself in those who are resistant to certain types of medicine.
Abacavir, dolutegravir, and lamivudine may also be used for purposes not listed in this medication guide.
Warnings
You should not take this medicine if you have ever had an allergic reaction to any medicine that contains abacavir, or if you have a gene variation called HLA-B*5701 allele. Also, you should not use this medicine if you have moderate or severe liver disease, or if you are also taking dofetilide (Tikosyn).
Stop using this medicine and call your doctor at once if you have any of these signs of an allergic reaction: fever; rash; nausea, vomiting, diarrhea, stomach pain; general ill feeling, extreme tiredness, body aches; shortness of breath, cough, sore throat.
If you've had hepatitis B, it may come back or get worse after you stop using abacavir, dolutegravir, and lamivudine. You may need frequent liver function tests for several months.
Before taking this medicine
You should not use abacavir, dolutegravir, and lamivudine if you are allergic to abacavir, dolutegravir, or lamivudine, or if:
you also take dofetilide (Tikosyn);
you have moderate or severe liver disease;
you have a gene variation called HLA-B*5701 allele (your doctor will test you for this); or
you have a history of allergic reaction to Combivir,...
